- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 333/34 - Sulfur atoms
Patent holdings for IPC class C07D 333/34
Total number of patents in this class: 307
10-year publication summary
16
|
25
|
19
|
12
|
19
|
19
|
16
|
17
|
18
|
3
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novartis AG | 11238 |
16 |
Allergan, Inc. | 2600 |
13 |
The Johns Hopkins University | 5377 |
12 |
Cardioxyl Pharmaceuticals, Inc. | 49 |
10 |
Wyeth | 632 |
6 |
Oxford Drug Design Limited | 9 |
6 |
The Institute of Cancer Research: Royal Cancer Hospital | 186 |
5 |
Kancera AB | 31 |
5 |
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 157 |
5 |
The University of Queensland | 666 |
5 |
Baylor College of Medicine | 875 |
4 |
IFM Tre, Inc. | 5 |
4 |
AstraZeneca AB | 3042 |
3 |
Syngenta Participations AG | 4970 |
3 |
Sumitomo Chemical Company, Limited | 8808 |
3 |
The Regents of the University of Michigan | 4409 |
3 |
Incyte Holdings Corporation | 609 |
3 |
Metabrain Research | 12 |
3 |
Pharmaxis Ltd | 43 |
3 |
Sumitomo Seika Chemicals Co., Ltd. | 1028 |
3 |
Other owners | 192 |